The Use of Intravenous Infliximab to Treat Cancer Related Fistulae: A Case Report in Home-Based Palliative Care Improving Quality of Life and Closure
Fistulae can severely impact a patient's quality of life, causing physical pain and excessive malodorous discharge. Beyond the physical symptoms, they also impose significant psychological and social burdens. This report presents a unique case involving the intravenous administration of a single dose of infliximab to a terminally ill patient with rectal adenocarcinoma complicated by severe enterocutaneous fistulae in the genital, subscrotal, and gluteal regions. This home-based intervention not only improved the patient's quality of life but also alleviated caregiver burdens and facilitated the timely completion of end-of-life tasks.
Authors
- Maria Paula Custódio
- Paula Câmara
- Miguel Julião (ORCID: https://orcid.org/0000-0001-9283-5045)
- Carolina Simões (ORCID: https://orcid.org/0000-0003-0714-3058)
- M. J. Gomes (ORCID: https://orcid.org/0000-0003-3690-0564)
- Inês Goulão
Institutions
- Hospital Prof. Dr. Fernando Fonseca (PT)
Publication Details
- Journal
- Journal of Pain & Palliative Care Pharmacotherapy
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1080/15360288.2025.2517770
- Primary Topic
- Amoebic Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00